racemetirosine has been researched along with Glial Cell Tumors in 5 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To develop a valid treatment strategy for recurrent high-grade gliomas using stereotactic hypofractionated reirradiation based on biologic imaging and temozolomide." | 3.73 | Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. ( Franz, M; Grosu, AL; Gumprecht, H; Molls, M; Nieder, C; Piert, M; Schwaiger, M; Stärk, S; Thamm, R; Weber, WA, 2005) |
| "The highest IMT uptake was found in a metastasis of lung carcinoma." | 1.31 | I-123-lodo-alpha-methyl tyrosine SPECT in non-parenchymal brain tumours. ( Franzius, Ch; Matheja, P; Palkovic, S; Rickert, Ch; Riemann, B; Schober, O; Weckesser, M, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matheja, P | 2 |
| Weckesser, M | 3 |
| Rickert, Ch | 1 |
| Franzius, Ch | 1 |
| Palkovic, S | 1 |
| Riemann, B | 3 |
| Schober, O | 3 |
| Papke, K | 1 |
| Hoess, N | 1 |
| Kuwert, T | 1 |
| Wassmann, H | 1 |
| Heindel, W | 1 |
| Grosu, AL | 1 |
| Weber, WA | 1 |
| Franz, M | 1 |
| Stärk, S | 1 |
| Piert, M | 1 |
| Thamm, R | 1 |
| Gumprecht, H | 1 |
| Schwaiger, M | 1 |
| Molls, M | 1 |
| Nieder, C | 1 |
| Kopka, K | 1 |
| Friedrich, M | 1 |
| Winters, S | 1 |
| Halfter, H | 1 |
| Stögbauer, F | 1 |
| Ringelstein, EB | 1 |
| Samnick, S | 1 |
| Bader, JB | 1 |
| Hellwig, D | 1 |
| Moringlane, JR | 1 |
| Alexander, C | 1 |
| Romeike, BF | 1 |
| Feiden, W | 1 |
| Kirsch, CM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme - a Randomised Phase II Trial[NCT01252459] | Phase 2 | 200 participants (Anticipated) | Interventional | 2011-07-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for racemetirosine and Glial Cell Tumors
| Article | Year |
|---|---|
Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up.
Topics: Adult; alpha-Methyltyrosine; Brain Neoplasms; Diagnosis, Differential; Enzyme Inhibitors; Female; Gl | 2002 |
4 other studies available for racemetirosine and Glial Cell Tumors
| Article | Year |
|---|---|
I-123-lodo-alpha-methyl tyrosine SPECT in non-parenchymal brain tumours.
Topics: Adult; Aged; alpha-Methyltyrosine; Biological Transport; Biopsy; Brain Neoplasms; Female; Glioma; Hu | 2002 |
Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-L-alpha-methyltyrosine SPECT.
Topics: Adult; Aged; Aged, 80 and over; alpha-Methyltyrosine; Astrocytoma; Biopsy; Brain; Brain Neoplasms; F | 2002 |
Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Topics: Adult; Aged; alpha-Methyltyrosine; Analysis of Variance; Antineoplastic Agents, Alkylating; Astrocyt | 2005 |
Characterization of 3-[(123)I]iodo-L-alpha-methyl tyrosine transport in astrocytes of neonatal rats.
Topics: alpha-Methyltyrosine; Amino Acid Transport Systems; Amino Acids, Cyclic; Animals; Animals, Newborn; | 2001 |